GRCU Discussion 08/22/2014 23:31:26 $GRCU I get the

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
GRCU Discussion 08/22/2014 23:31:26 $GRCU
I get the feeling this thing is being bought up at low prices from several entities for some powerful people in the know.

Taking advantage of these prices and loading up on the fear that almost looks orchestrated. Looks like a potential positive turn around play here. We are betting money on it!
You mean 2014 right 2015 is next year

GRCU Stock Message Board http://investorshangout.com/Green-Cures-and-B...RCU-67874/

I am giving him until end of 2nd qtr FINS in 2015

If he hasn't steered the ship by then I am selling out and taking my lumps. If we don't make it I am willing to take the 100% loss

This is a startup and one year at the helm will tell me if he is "DA MAN" or "DA DUD"

My DD indicates the former and not the latter however people with fantastic reputations and experience do not always succeed 100% of the time

I am banking that this is one that he is successful in

Further accumulation of shares are on hold however until he proves to me that further investment is worth the risk of additional capital on my end. These ultra cheap shares though are very tempting but waiting a little longer as I can see .007 or .006 more tempting and a more worthwhile risk

If it doesn't hit those levels however I am perfectly alright with it

All have a great weekend and lets be hopeful of a better week ahead in GRCU land and a Calkin who has awaken from his nap
20 Medical Studies That Show Cannabis Can Cure Cancer

August 23, 2013 by Arjun Walia. 508 Comments.

Cannabis has been making a lot of noise lately. Multiple states across the United States and countries around the world have successfully legalized medical Marijuana, and the Uruguay parliament recently voted to create the world’s first legal marijuana market. This is good news as the health benefits of Cannabis are vast, with multiple medical and scientific studies that confirm them. On the other hand, arguments against the use of marijuana is usually published in Psychiatric journals, which show no scientific evidence that Cannabis is harmful to human health. All psychological evaluations from the intake of cannabis are largely based on assumptions, suggestions and observations (1). When we look at the actual science behind Cannabis, the health benefits can be overwhelming. So what does one who opposes the use of cannabis base their belief on? Nothing, not scientific evidence anyways. The negative stigmatism attached to marijuana is due to it’s supposed psychotropic effects, yet again, there is no scientific evidence to show that marijuana has any psychotropic effects. Nonetheless, cannabis has recently been the focus of medical research and considered as a potential therapeutic treatment and cure for cancer.

Cannabis is a great example of how the human mind is programmed and conditioned to believe something. Growing up, we are told drugs are bad, which is very true, however not all substances that have been labelled as “drugs” by the government are harmful. Multiple substances are labelled as a “drug” in order to protect corporate interests. One example is the automobile and energy industry, a car made from hemp is stronger than steel, and can be fuelled from hemp alone. Henry Ford demonstrated this many years ago. Hemp actually has over 50,000 uses!

Let’s take a look at the science behind Cannabis and Cancer. Although Cannabis has been proven to be effective for a large range of ailments, this article will focus mainly on it’s effectiveness in the treatment of cancer. Cannabinoids may very well be one of the best disease and cancer fighting treatments out there. Cannabinoids refer to any of a group of related compounds that include cannabinol and the active constituents of cannabis. They activate cannabinoid receptors in the body. The body itself produces compounds called endocannabinoids and they play a role in many processes within the body that help to create a healthy environment. Cannabinoids also play a role in immune system generation and re-generation. The body regenerates best when it’s saturated with Phyto-Cannabinoids. Cannabinoids can also be found in Cannabis. It is important to note that the cannabinoids are plentiful in both hemp and cannabis. One of the main differentiations between hemp and cannabis is simply that hemp only contains 0.3% THC while cannabis is 0.4% THC or higher. (Technically they are both strains of Cannabis Sativa.) Cannabinoids have been proven to reduce cancer cells as they have a great impact on the rebuilding of the immune system. While not every strain of cannabis has the same effect, more and more patients are seeing success in cancer reduction in a short period of time by using cannabis.

While taking a look at these studies, keep in mind that cannabis can be much more effective for medicinal purposes when we eat it rather than smoking it. Below are 20 medical studies that prove cannabis can be an effective treatment and possible cure for cancer. Please keep in mind that this is a very short list of studies that support the use of medicinal marijuana. Please feel free to further your research, hopefully this is a good starting point.

Brain Cancer
1. A study published in the British Journal of Cancer, conducted by the Department of Biochemistry and Molecular Biology at Complutense University in Madrid, this study determined that Tetrahydrocannabinol (THC) and other cannabinoids inhibit tumour growth. They were responsible for the first clinical study aimed at assessing cannabinoid antitumoral action. Cannabinoid delivery was safe and was achieved with zero psychoactive effects. THC was found to decrease tumour cells in two out of the nine patients.

2. A study published in The Journal of Neuroscience examined the biochemical events in both acute neuronal damage and in slowly progressive, neurodegenerative diseases. They conducted a magnetic resonance imaging study that looked at THC (the main active compound in marijuana) and found that it reduced neuronal injury in rats. The results of this study provide evidence that the cannabinoid system can serve to protect the brain against neurodegeneration.

3. A study published in The Journal of Pharmacology And Experimental Therapeutics already acknowledged the fact that cannabinoids have been shown to possess antitumor properties. This study examined the effect of cannabidiol (CBD, non psychoactive cannabinoid compound) on human glioma cell lines. The addition of cannabidiol led to a dramatic drop in the viability of glioma cells. Glioma is the word used to describe brain tumour. The study concluded that cannabidiol was able to produce a significant antitumor activity.

4. A study published in the journal Molecular Cancer Therapeutics outlines how brain tumours are highly resistant to current anticancer treatments, which makes it crucial to find new therapeutic strategies aimed at improving the poor prognosis of patients suffering from this disease. This study also demonstrated the reversal of tumour activity in Glioblastoma multiforme.

Breast Cancer
5. A study published in the US National Library of Medicine, conducted by the California Pacific Medical Centre determined that cannabidiol (CBD) inhibits human breast cancer cell proliferation and invasion. They also demonstrated that CBD significantly reduces tumour mass.

6. A study published in The Journal of Pharmacology and Experimental Therapeutics determined that THC as well as cannabidiol dramatically reduced breast cancer cell growth. They confirmed the potency and effectiveness of these compounds.

7. A study published in the Journal Molecular Cancer showed that THC reduced tumour growth and tumour numbers. They determined that cannabinoids inhibit cancer cell proliferation, induce cancer cell apoptosis and impair tumour angiogenesis (all good things). This study provides strong evidence for the use of cannabinoid based therapies for the management of breast cancer.

8. A study published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) determined that cannabinoids inhibit human breast cancer cell proliferation.

Lung Cancer
9. A study published in the journal Oncogene, by Harvard Medical Schools Experimental Medicine Department determined that THC inhibits epithelial growth factor induced lung cancer cell migration and more. They go on to state that THC should be explored as novel therapeutic molecules in controlling the growth and metastasis of certain lung cancers.

10. A study published by the US National Library of Medicine by the Institute of Toxicology and Pharmacology, from the Department of General Surgery in Germany determined that cannabinoids inhibit cancer cell invasion. Effects were confirmed in primary tumour cells from a lung cancer patient. Overall, data indicated that cannabinoids decrease cancer cell invasiveness.

11. A study published by the US National Library of Medicine, conducted by Harvard Medical School investigated the role of cannabinoid receptors in lung cancer cells. They determined its effectiveness and suggested that it should be used for treatment against lung cancer cells.

Prostate Cancer
12. A study published in the US National Library of Medicine illustrates a decrease in prostatic cancer cells by acting through cannabinoid receptors.

13. A study published in the US National Library of Medicine outlined multiple studies proving the effectiveness of cannabis on prostate cancer.

14. Another study published by the US National Library of Medicine determined that clinical testing of CBD against prostate carcinoma is a must. That cannabinoid receptor activation induces prostate carcinoma cell apoptosis. They determined that cannabidiol significantly inhibited cell viability.

Blood Cancer
15. A study published in the journal Molecular Pharmacology recently showed that cannabinoids induce growth inhibition and apoptosis in matle cell lymphoma. The study was supported by grants from the Swedish Cancer Society, The Swedish Research Council and the Cancer Society in Stockholm.

16. A study published in the International Journal of Cancer also determined and illustrated that cannabinoids exert antiproliferative and proapoptotic effects in various types of cancer and in mantle cell lymphoma.

17. A study published in the US National Library of Medicine conducted by the Department of Pharmacology and Toxicology by Virginia Commonwealth University determined that cannabinoids induce apoptosis in leukemia cells.

Oral Cancer
18. A study published by the US National Library of Medicine results show cannabinoids are potent inhibitors of cellular respiration and are toxic to highly malignant oral Tumours.

Liver Cancer
19. A study published by the US National Library of Medicine determined that that THC reduces the viability of human HCC cell lines (Human hepatocellular liver carcinoma cell line) and reduced the growth.

Pancreatic Cancer
20. A study published in The American Journal of Cancer determined that cannabinoid receptors are expressed in human pancreatic tumor cell lines and tumour biopsies at much higher levels than in normal pancreatic tissue. Results showed that cannabinoid administration induced apoptosis. They also reduced the growth of tumour cells, and inhibited the spreading of pancreatic tumour cells.

Sources:

All sources highlighted throughout article. Click on the highlighted parts of the article to view them.

1)http://bjp.rcpsych.org/content/178/2/116.full

#GRCU
The more I think about it the more I am convinced you are right. However I also see it from Calkin's perspective that by putting out a PR people are going to get spooked, some will say fluff, shorts will use it as an opportunity to bring down the PPS even more, and competitors may gain advantageous information. There is probably a happy midpoint somewhere but at this time I would tend to side with Calkin and mum's the word while he feverishly tries to solve the problem. Let's give him another week.
They've kept investors up to date honestly till a month ago and its fallen on deaf ears. Bashers/shorts love that shit. Future plans, this is what were doing, yada, yada, yada. They took it down. I think Calkin sees no reason to feed into the bullshit. Now the only news we're gonna get is going to be concrete. And massive

GRCU
We both have different opinions and that is fine.

There is nothing wrong with not being in 100% in total agreement.

I expect more transparency and honesty from Calkin and you are pleased with his current amount of transparency and honesty

Nothing wrong with that.




Not an issue. CCI will take back seat...matter of time. Robert wouldn't have gone down this road if he wanted CCI to be the main attraction.

GRCU
Rick I believe that they are both related.

I can assure you that if product was available the site would be up and accepting orders

Just be honest with your shareholders, come out and let us know that we are behind and doing our best to get the product in stock and the site and running

That is all that I and many fellow shareholders are asking

Accept the backlash for being honest. He will gain more respect versus hiding behind a closed door. Believe it or not real shareholders will accept the mistake and delays if kept abreast however when you go silent then all the speculation arises which creates instability in the marketplace and we have plenty of that
GRCU most transparent company in the OTC. Unless you are someone who's an expert in the CBD industry then you know what you're talking about; otherwise, you're just doing what average minds would do imo, claim to know it all and point at what they think is wrong but you haven't even been right from the start. GRCU not for flippers imo.
Maybe I am being impatient that something as simple as a website that was highly touted would still be in "TEST" mode a week after launch and that the Pills continue to be out of stock for weeks and promises of supply have passed multiple times

Maybe expecting the basics and keeping promises are too much to ask.



What do you make of Philipt631 argument that Calkin is spending too much time with CCI and not with GRCU ? That CCI website works perfectly yet Green Cures website is stuck in test mode for one week now ?
OK I agree one week test mode is ridiculous. I have been checking every few hours and test mode continues. I don't think anybody is actually monitoring this website. Personally I think it is a supply issue with the CBD product and has nothing to do with test mode.
Me too bud! I like money don't get me wrong. Its not all that makes the world go round....but at a penny...no brainer!

GRCU
Lack of transparency from Calkin continues

Too much effort going into CCI and not enough in GRCU

I bet the CCI website works perfectly, you can register for classes and order CCI training products. Plenty in stock

For CB website continues to be in "TEST" mode and the only real money making product continues to be out of stock. Revenue that should be going to GRCU is going to the competitors. Do you find it acceptable that sales that should be in our coffers are going elsewhere? am greedy and don't care about the success of the competitors

Lab results are great but if you do not have product to sell does that show a leader in control of the ship?

I am a realist and extremely patient. I am giving Calkin every opportunity to perform and in the end I believe that he will.

At this point I believe he is lacking the transparency that he preached when he took over, is having a tough time juggling his schedule to devote all the time that is needed to build GRCU and his other companies. However as an investor in GRCU and not his other ventures I couldn't give to "%^$#" about his other ventures and their success. I care about GRCU and it's success and believe it or not I also wish for my fellow longs to be profitable in their investment in GRCU.










Greed is human natures way of protecting its own. Take from the other one before they take from you. Capitalism at its finest. Green Cures management believes in fairness and I agree ,with that 100%.
They're not coming to market with a new snowboard design or a new cell phone.
They're selling something that will stop your 5 year old from having seizures, something that will halt the onset of your parents Alzheimer's and kill cancer dead in its tracks.
Legal or not its right.
Green Cures is bringing what they can to the fight under current laws given being they are a publicly traded entity.
Its all changing. Quickly too.


GRCU


Great post Q! Also, those newbies that bought in were an inexperienced and impatient bunch. GRCU is in better shape now than at $.049. Keep selling people...I'll buy em'.

I read all your posts and generally agree except this time. You can not say that Calkin is ignoring GRCU and concentrating on CCI just because there has been no PR released in 5 weeks. In fact the financials released August 15 constitutes the biggest PR you could possibly ask for. Do you desire for Calkin to summarize the financials and then issue a summary PR ? CCI is on autopilot and Calkin has many other folks under his umbrella running the show. He has moved onto his next project that being GRCU. It's pretty obvious from the financials and the product rollout he is devoting a lot of time and effort. PPS will be $0.04 by Dec 31 mark my words.
What a great post Quinton. I am with you all the way. I also noticed that with each PR the price would fall. I would do the same if I were Calkin and stop putting out PR's. I also agree with somebody else earlier who said that the recent financials released August 15 really was another form of a PR.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celebrating Leaders Advancing Type 1 Diabetes Research

Updated Category News Views 62

Honoring Trailblazers in Type 1 Diabetes Research It's not every day that we get to shine a spotlight on the unsung heroes in the field of Type 1 Diabetes (T1D) research. Today, we pause to celebrate those who are doing the heavy lifting to make the lives of millions better. Breakthrough T1D, the name says it all, presented its prestigious awards to four titans of...

Continue Reading
Hitachi's Smart Energy Move: AI Capacity Boost Unveiled

Updated Category News Views 95

Tackling Energy Challenges in Data Centers Data centers are struggling to keep up with the surging demand for computing power fueled by artificial intelligence, but Hitachi Vantara is flipping the script on how to handle it. Over in the Netherlands, they're working some serious tech magic by deploying a groundbreaking method to wrangle energy use and boost AI capability...

Continue Reading
OriginPoint Boosts Growth with $200M Lender Team

Updated Category News Views 22

Mortgage Powerhouses Join Forces with OriginPoint It's not every day you see a $200 million mortgage team making a beeline for new pastures, but today's landscape seems ripe for such moves. Enter the We Fund LA team, led by mortgage veterans Daniel Arias and Ron Sequeira, as they align with OriginPoint Mortgage to scale new heights in Southern California. This isn't just...

Continue Reading
Elbit Systems Poised for Q3 2026 Earnings Reveal

Updated Category News Views 53

Elbit Systems: A Strategic Player in Defense Here's what's going on with Elbit Systems Ltd. (NASDAQ:ESLT), the Israeli defense heavy hitter. They're gearing up to spill the beans on their Q3 financial results this November 17th. And for those of us keeping an eye on how defense contractors are adapting to today's chaotic geopolitical climate, this is a date you don't want...

Continue Reading
Nevada King's Gold Drilling Could Yield Big Returns

Updated Category News Views 64

Unlocking Gold's Potential: A First Look Another day, another drill result, and this time it's Nevada King Gold Corp. (TSXV: NKG) (OTCQX: NKGFF) dropping the headlines. They've been playing in the dirt at their Atlanta Gold Mine Project in Nevada, unveiling numbers that might shake some of you out of your chairs. Peeking Into East Ridge and Silver Park Let's talk turkey,...

Continue Reading
Multiplier's Data Signals Global Hiring Evolution

Updated Category News Views 0

Shaking Up the Global Hiring Playbook You think you know how hiring works globally? Think again. Based on data from a whopping 38,000 cross-border hires, Multiplier's latest Talent Trends has spilled some hot new beans on how companies are rethinking their talent acquisition strategies. This isn’t just some thumb-twiddling speculation either—it’s grounded in real...

Continue Reading
Venezuelan Crude Hits Texas: NABEP's Bold Move

Updated Category News Views 90

Venezuelan Crude Docking in Texas Signals New Energy Dynamics Batten down the hatches, 'cause NABEP's Venezuelan crude has made a splashy arrival in Texas. We're talking 1 million barrels, folks, the first of its kind under a fresh U.S. deal. This ain't your grandpa's oil shipment from the Middle East that takes forever to get here—nope, this crude made a pit stop in...

Continue Reading
Backroads Invites Families: Adventures Boost Bookings by 20%

Updated Category News Views 118

Rediscovering Family Time Through Adventure When was the last time a winter vacation got you this fired up? Backroads, the trailblazer in active getaways, is bucking the trend of typical holiday madness. Families are ditching the usual gift-giving grind for something way more memorable: experiences that blend action with bonding across generations. Big Numbers, Big...

Continue Reading
Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 91

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
mainelove Rides High With Double Gold and Growth

Updated Category News Views 69

mainelove Shakes Up the Water Scene Well ain't that a splash? mainelove, the Maine-sourced water outfit, just snagged itself some shiny Double Gold hardware at the 2026 Water Choice Awards. Makes you raise a glass—or a can, I suppose—to see a local brand licking its chops over a win like this. It's not every day you hear a water company nailing it across state lines,...

Continue Reading
>